Growth Clinical Trials in Seattle, Washington
7 recruitingSeattle, Washington
Showing 1–7 of 7 trials
Recruiting
Phase 2
Growth Hormone Replacement in Veterans With GWI and AGHD (GWIT)
Adult Growth Hormone DeficiencyGulf War Syndrome
Baylor College of Medicine20 enrolled2 locationsNCT05355272
Recruiting
Phase 3
Phase 3 Study of LUM-201 in Children With Growth Hormone Deficiency
Growth Hormone Deficiency (GHD)
Lumos Pharma150 enrolled28 locationsNCT06948214
Recruiting
Phase 2
A Phase 2 Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, in Adults and Children With PIK3CA Related Overgrowth Spectrum and Malformations Driven by PIK3CA Mutation
PIK3CA MutationVascular MalformationsPIK3CA-Related Overgrowth Spectrum (PROS)+4 more
Relay Therapeutics, Inc.277 enrolled31 locationsNCT06789913
Recruiting
A US Non-interventional, Effectiveness and Safety Study of Patients Treated With SKYTROFA
Growth Hormone Deficiency
Ascendis Pharma Endocrinology Division A/S900 enrolled27 locationsNCT05820672
Recruiting
Phase 3
Growth Hormone Replacement Therapy in Veterans With Mild Traumatic Brain Injury (mTBI) and Adult Growth Hormone Deficiency (AGHD)
Mild Traumatic Brain InjuryAdult Growth Hormone Deficiency
VA Office of Research and Development172 enrolled4 locationsNCT04867317
Recruiting
Phase 1Phase 2
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Triple-Negative Breast CancerEndometrial CancerPrimary Peritoneal Carcinoma+12 more
Genmab764 enrolled66 locationsNCT05579366
Recruiting
A Post-Authorisation Safety Study (PASS) of Patients Treated With Lonapegsomatropin
Growth Hormone Deficiency
Ascendis Pharma Endocrinology Division A/S500 enrolled27 locationsNCT05775523